Viral Hepatitis
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3722-3728
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3722
Table 1 Characteristics of patients with different response to IFN therapy
Sustained respondersNon-respondersP
Patients (n)1669
Age (yr)51.2 ± 10.752.4 ± 11.1NS
Male/Female14/247/22NS
History of blood5/1121/48NS
transfusion (+/-)
ALT (IU/I)110.4 ± 88.095.6 ± 61.0NS
Viral load (Meq/mL)0.9 ± 0.96.9 ± 7.80.0027
Histology
Grade1.9 ± 0.72.3 ± 0.8NS
Stage1.9 ± 0.72.5 ± 0.90.0154
Number of amino acid
Substitutions in
ISDR5.0 ± 1.20.7 ± 1.1< 0.0001
C-terminal part of E23.4 ± 1.72.5 ± 1.20.0149
N-terminal variable region1.6 ± 1.10.9 ± 0.90.0148
Substitution of aa 625 (+/-)6/108/610.0213

  • Citation: Ukai K, Ishigami M, Yoshioka K, Kawabe N, Katano Y, Hayashi K, Honda T, Yano M, Goto H. Mutations in carboxy-terminal part of E2 including PKR/eIF2α phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: Their correlation with response to interferon monotherapy and viral load. World J Gastroenterol 2006; 12(23): 3722-3728
  • URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3722.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3722